These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6214994)

  • 1. Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.
    Kayser FH; Morenzoni G; Homberger F
    Antimicrob Agents Chemother; 1982 Jul; 22(1):15-22. PubMed ID: 6214994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.
    Kojo H; Nishida M; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1979 Nov; 16(5):549-53. PubMed ID: 316684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin.
    Cherubin CE; Eng RH; Smith SM; Goldstein EJ
    Arch Intern Med; 1986 Nov; 146(11):2149-52. PubMed ID: 3490834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporins.
    Adamsson L; Dornbusch K; Hallander HO
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():153-62. PubMed ID: 19802979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cefamandole, cefoxitin, cefuroxime, cefotaxime and cefoperazone: an in vitro test on a number of beta-lactamase producing strains of 9 species and 1 genus of bacteria.
    Kuipers JS
    Curr Med Res Opin; 1981; 7(3):196-203. PubMed ID: 6971210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.
    Strandberg DA; Jorgensen JH; Drutz DJ
    Diagn Microbiol Infect Dis; 1984 Sep; 2(4):333-7. PubMed ID: 6333316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriostatic and bactericidal activities of selected beta-lactam antibiotics studied on agar plates.
    Masuda G; Tomioka S; Uchida H; Hasegawa M
    Antimicrob Agents Chemother; 1977 Mar; 11(3):376-82. PubMed ID: 855996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 May; 45(5):1585-8. PubMed ID: 11302835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid method for determining antimicrobial susceptibility of Haemophilus influenzae.
    Smith JA; Ngui-Yen JH; Fothergill J; Porter D
    J Clin Microbiol; 1982 Nov; 16(5):832-5. PubMed ID: 6984049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.
    Bergeron MG; Simard P; Provencher P
    J Clin Microbiol; 1987 Apr; 25(4):650-5. PubMed ID: 3494745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of faropenem against beta-lactamase producing clinical isolates].
    Nishiyama T; Matsuzaki K; Koyama H; Saika T; Hasegawa M; Kobayashi I
    Jpn J Antibiot; 2000 Mar; 53(3):179-83. PubMed ID: 10834149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics.
    Jones RN; Barry AL
    Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.